JPH11279199A5 - - Google Patents

Info

Publication number
JPH11279199A5
JPH11279199A5 JP1999012610A JP1261099A JPH11279199A5 JP H11279199 A5 JPH11279199 A5 JP H11279199A5 JP 1999012610 A JP1999012610 A JP 1999012610A JP 1261099 A JP1261099 A JP 1261099A JP H11279199 A5 JPH11279199 A5 JP H11279199A5
Authority
JP
Japan
Prior art keywords
blood coagulation
monoclonal antibody
factor vii
coagulation factor
activated blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1999012610A
Other languages
English (en)
Japanese (ja)
Other versions
JP4422228B2 (ja
JPH11279199A (ja
Filing date
Publication date
Priority claimed from DE19802139A external-priority patent/DE19802139C1/de
Application filed filed Critical
Publication of JPH11279199A publication Critical patent/JPH11279199A/ja
Publication of JPH11279199A5 publication Critical patent/JPH11279199A5/ja
Application granted granted Critical
Publication of JP4422228B2 publication Critical patent/JP4422228B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP01261099A 1998-01-22 1999-01-21 活性化血液凝固第ｖｉｉ因子に特異的なモノクローナル抗体およびその使用 Expired - Fee Related JP4422228B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802139A DE19802139C1 (de) 1998-01-22 1998-01-22 Monoklonaler Antikörper spezifisch für aktivierten Gerinnungsfaktor VII und seine Verwendung
DE19802139:9 1998-01-22

Publications (3)

Publication Number Publication Date
JPH11279199A JPH11279199A (ja) 1999-10-12
JPH11279199A5 true JPH11279199A5 (enExample) 2006-04-06
JP4422228B2 JP4422228B2 (ja) 2010-02-24

Family

ID=7855234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP01261099A Expired - Fee Related JP4422228B2 (ja) 1998-01-22 1999-01-21 活性化血液凝固第ｖｉｉ因子に特異的なモノクローナル抗体およびその使用

Country Status (9)

Country Link
US (2) US6479245B1 (enExample)
EP (1) EP0931793B1 (enExample)
JP (1) JP4422228B2 (enExample)
KR (1) KR100583537B1 (enExample)
AT (1) ATE261991T1 (enExample)
AU (1) AU742631B2 (enExample)
CA (1) CA2259724C (enExample)
DE (2) DE19802139C1 (enExample)
ES (1) ES2217492T3 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802139C1 (de) * 1998-01-22 1999-09-23 Centeon Pharma Gmbh Monoklonaler Antikörper spezifisch für aktivierten Gerinnungsfaktor VII und seine Verwendung
JP4309656B2 (ja) * 2000-12-14 2009-08-05 ジェネンテック・インコーポレーテッド 原核生物で生成させた抗体とその用途
AU2002327192B2 (en) * 2001-07-03 2007-02-15 Oklahoma Medical Research Foundation Assay for measuring factor VIIa-antithrombin complexes
CA3135632A1 (en) 2019-04-17 2020-10-22 Novo Nordisk A/S Bispecific antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506134A (en) * 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
US5843442A (en) * 1990-10-22 1998-12-01 Corvas International, Inc. Blood coagulation protein antagonists and uses therefor
MX9204374A (es) * 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
MA24512A1 (fr) * 1996-01-17 1998-12-31 Univ Vermont And State Agrienl Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose
DE19802139C1 (de) * 1998-01-22 1999-09-23 Centeon Pharma Gmbh Monoklonaler Antikörper spezifisch für aktivierten Gerinnungsfaktor VII und seine Verwendung

Similar Documents

Publication Publication Date Title
WO2005035584A8 (en) Fully human antibodies against human 4-1bb (cd137)
IL261019A (en) Antibodies to 6 -il and their use
Reidenberg The binding of drugs to plasma proteins from patients with poor renal function
ATE195533T1 (de) Monoklonale antikörper gegen den tie-rezeptor und deren verwendung
WO2004022718A3 (en) Therapeutic human anti-il-1r1 monoclonal antibody
KR950005327A (ko) 임파구 항원 CD2 및 종양 항원을 인식하는 이특이적 트리거(Trigger) 분자
GB9009548D0 (en) Chimeric antibody and method
ATE280783T1 (de) Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis
WO1999058570A3 (en) Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis
WO2004066932A3 (en) Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
JP2002535285A5 (enExample)
DE60329823D1 (de) Antikörper mit t-zell-rezeptor-artiger spezifität, aber höherer affinität und seine verwendung zum nachweis und zur behandlung von krebs, virusinfektionen und autoimmunkrankheiten
ATE208596T1 (de) Verfahren zur kontrolle von b-zellenpopulation
PL406852A1 (pl) Preparat zawierający ludzkie przeciwciała do leczenia zaburzeń związanych z TNF-α
ATE286742T1 (de) Behandlung von nierenfibrose durch antikörper gegen integrin alpha-v-beta 6
NZ337072A (en) use of an anti-CD40L compounds to inhibit the progression of nephritis, stabilize nephritis or reverse nephritis in a patient with an immune complex disease
JP2020513757A5 (enExample)
TW200517124A (en) Fully human antibodies against human 4-1BB
WO2005026210A3 (en) Therapeutic binding molecules
PT628077E (pt) Anticorpos humanizados direccionados contra o antigenio de a33
JPH11279199A5 (enExample)
IT1284076B1 (it) Frammenti f(ab')2 e relative immunoglobuline igg, attivi come anticorpi specifici verso farmaci e i loro metaboliti, e loro
WO2001037874A3 (en) Treatment of psoriasis by using an antibody to tnf alpha
CA2259724A1 (en) Monoclonal antibody which is specific for activated coagulation factor vii, and its use
WO2023164581A3 (en) Fully human monoclonal antibodies against human progranulin